Literature DB >> 655661

Carotid and vertebral-basilar transient ischemic attacks: effect of anticoagulants, hypertension, and cardiac disorders on survival and stroke occurrence--a population study.

J P Whisnant, N E Cartlidge, L R Elveback.   

Abstract

A population of 199 patients from Rochester, MN, was followed from the time of their first carotid or vertebral-basilar transient ischemic attack (TIA). Patients treated with anticoagulants had no significant difference in survival from untreated patients. Among patients with carotid TIA who received anticoagulants, the net probability of stroke was slightly but not significantly lower than in untreated patients. The difference favoring treated patients with vertebral-basilar TIA was significant starting at three months. The rate of intracranial hemorrhage was higher higher among all patients receiving anticoagulant treatment than among untreated patients and was significantly higher among those 55 to 74 years old. Almost all the hemorrhages occurred after a year or more of anticoagulant treatment and in patients more than 65 years old. Patients with high diastolic blood pressure had a significantly higher net probability of stroke than did patients with lower blood pressure and those receiving antihypertensive drugs. By implication, treatment of hypertension was effective in preventing stroke in patients with TIA. Linear discriminant analysis and actuarial analysis indicated that diastolic blood pressure and anticoagulant therapy were the only factors that influenced stroke occurrence. There was no suggestion that previous myocardial infarction, angina pectoris, valvular heart disease, cardiac arrhythmia, or congestive heart failure--individually or in combination--influenced the occurrence of stroke or survival.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 655661     DOI: 10.1002/ana.410030204

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  18 in total

1.  Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events?

Authors:  G J Hankey; J M Slattery; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

Review 2.  Outcome of transient ischaemic attacks and stroke.

Authors:  J W Norris
Journal:  Drugs       Date:  1991       Impact factor: 9.546

3.  Vertebrobasilar Flow Evaluation and Risk of Transient Ischaemic Attack and Stroke study (VERiTAS): rationale and design.

Authors:  Sepideh Amin-Hanjani; Linda Rose-Finnell; DeJuran Richardson; Sean Ruland; Dilip Pandey; Keith R Thulborn; David S Liebeskind; Gregory J Zipfel; Mitchell S V Elkind; Jeffrey Kramer; Frank L Silver; Scott E Kasner; Louis R Caplan; Colin P Derdeyn; Philip B Gorelick; Fady T Charbel
Journal:  Int J Stroke       Date:  2010-12       Impact factor: 5.266

Review 4.  Drug treatment of stroke. Current status and future prospects.

Authors:  C A Sila; A J Furlan
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

Review 5.  Atrial fibrillation, stroke and anticoagulation: what is to be done?

Authors:  J M Kitchens; K M Flegel
Journal:  J Gen Intern Med       Date:  1986 Mar-Apr       Impact factor: 5.128

6.  Controversies in the medical management of stroke.

Authors: 
Journal:  West J Med       Date:  1985-01

7.  Surgical versus nonoperative treatment of symptomatic carotid stenosis. 211 patients documented by intravenous angiography.

Authors:  N R Hertzer; R A Flanagan; E G Beven; P J O'Hara
Journal:  Ann Surg       Date:  1986-08       Impact factor: 12.969

Review 8.  Clinical evaluation and management of transient ischemic attacks.

Authors:  J F Rothrock
Journal:  West J Med       Date:  1987-04

Review 9.  Risk of haemorrhage associated with long term anticoagulant therapy.

Authors:  M N Levine; G Raskob; J Hirsh
Journal:  Drugs       Date:  1985-11       Impact factor: 9.546

10.  The surgical management of vertebrobasilar insufficiency.

Authors:  R A de los Reyes; J I Ausman; F G Diaz; H Pak; J E Pearce; M Dujovny
Journal:  Acta Neurochir (Wien)       Date:  1983       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.